Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 21:32 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems
NCT03098680 · Cambridge University Hospitals NHS Foundation Trust · PHASE1 · terminated · last registry update 2021-03-22 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Unable to recruit in time before end of PhD studentship” | – | Registry record, Cambridge University Hospitals NHS Foundation Trust |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against ADRB2 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2022-03-11Phase 3 first posted: Centre Hospitalier Universitaire, Amiens, Ephedrine + Norepinephrine (NCT05276596)
- 2021-10-29Phase 3 first posted: St. Justine's Hospital, Dexmedetomidine 0.004 MG/ML [Precedex] + Opioids (NCT05099055)
- 2021-10-28Also stopped (withdrawn): National Institute of Allergy and Infectious Diseases (NIAID), Pseudoephedrine hydrochloride + Guaifenesin (NCT00000752)
- 2021-07-22Phase 3 first posted: Kanecia Obie Zimmerman, Terbutaline (NCT04973345)
- 2021-05-05Also stopped (terminated): Vanderbilt University, Pseudoephedrine + 480 ml water + Pseudoephedrine + 50 ml water (NCT02149901)
- 2021-04-08Results posted on the registry: Medstar Health Research Institute, Modern medical management + Optimal medical therapy (NCT00074724)
- 2021-02-08Phase 3 first posted: University of Pecs, Standard medical therapy (NCT04742764)
- 2021-01-12Phase 3 first posted: Centre Hospitalier Intercommunal Creteil, Budesonide Formoterol Drug Combination + nebulisation of terbutaline (NCT04705727)
- 2020-11-03Phase 3 first posted: Ataturk University, ondansetron + Granisetron (NCT04613726)
- 2020-10-14Results posted on the registry: Duke University, Phenylephrine + Ephedrine (NCT02025426)
- 2020-10-14Also stopped (terminated): Duke University, Phenylephrine + Ephedrine (NCT02025426)
- 2020-10-09Results posted on the registry: Icahn School of Medicine at Mount Sinai, Bupivacaine + Terbutaline (NCT03106753)
- 2020-10-09Also stopped (terminated): Icahn School of Medicine at Mount Sinai, Bupivacaine + Terbutaline (NCT03106753)
- 2020-09-18Also stopped (terminated): Karolinska Institutet, a drug against ADRB2 (NCT01141894)
- 2020-08-05Results posted on the registry: Bracco Diagnostics, Inc, Lumason (NCT02552238)
- 2020-08-05Results posted on the registry: Bracco Diagnostics, Inc, Lumason (NCT02522481)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision